• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅颈肌张力障碍患者的生活质量:“颈椎肌张力障碍影响量表(CDIP-58)”和“颅颈肌张力障碍问卷(CDQ-24)”的意大利验证。

Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)".

机构信息

IRCCS Institute of Neurological Sciences, Via Altura 3, 40139, Bologna, Italy,

出版信息

Neurol Sci. 2014 Jul;35(7):1053-8. doi: 10.1007/s10072-014-1642-7. Epub 2014 Jan 30.

DOI:10.1007/s10072-014-1642-7
PMID:24477322
Abstract

Dystonia is a disabling and disfiguring disorder that can often affect many aspects of patients' daily lives, and lower their self-esteem. To date, quality of life (QoL) has been assessed in dystonic patients using generic measures that do not address the specific problems of this diagnostic group. Recently, two disease-specific scales "The Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)" were validated for measuring QoL in craniocervical dystonia patients. No disease-specific scales for QoL for dystonic patients are currently available in Italian. The aim of our study was to produce and validate the Italian version of the CDIP-58 and CDQ-24. We obtained the Italian version of CDQ-24 and CDIP-58 with a back-translation design. Both scales were applied to a population of 94 craniocervical dystonia patients along with the Short Form 36 health-survey questionnaire (SF-36), both before and 4 weeks after botulinum toxin therapy. A group of 65 controls matched for sex, age and comorbidity underwent the SF-36. Internal consistency was satisfactory for all subscales. Both the CDIP-58 and CDQ-24 showed moderate to high correlations with similar items of the SF-36. Sensitivity to change was confirmed by highly significant improvements in all CDQ-24 subscales and by moderate improvements in three out of eight CDIP-58 subscales and total score. This is the first Italian study on QoL in dystonia patients. We validated the Italian version of two disease-specific questionnaires to evaluate QoL in craniocervical dystonia patients. These scales could be useful for both clinical practice and clinical trials.

摘要

肌张力障碍是一种使人丧失能力且使人毁容的疾病,它常常会影响患者日常生活的许多方面,并降低他们的自尊心。迄今为止,人们使用通用的评估方法来评估肌张力障碍患者的生活质量(QoL),这些方法无法解决该诊断组的具体问题。最近,两种疾病特异性量表“颈肌张力障碍影响量表(CDIP-58)”和“颅颈肌张力障碍问卷(CDQ-24)”已被验证可用于测量颅颈肌张力障碍患者的 QoL。目前,尚无针对意大利语的肌张力障碍患者的特定疾病 QoL 量表。我们的研究旨在制作和验证 CDIP-58 和 CDQ-24 的意大利语版本。我们使用反向翻译设计获得了 CDQ-24 和 CDIP-58 的意大利语版本。这两个量表均应用于 94 例颅颈肌张力障碍患者,以及使用肉毒杆菌毒素治疗前后的简短形式 36 健康调查问卷(SF-36)。一组 65 名性别、年龄和合并症相匹配的对照组接受了 SF-36 测试。所有子量表的内部一致性均令人满意。CDIP-58 和 CDQ-24 与 SF-36 的相似项目均显示出中度至高度相关性。CDQ-24 的所有子量表以及 CDIP-58 的三个子量表和总分均显示出显著的变化敏感性,表明所有量表均具有较高的敏感性。这是意大利语肌张力障碍患者 QoL 的第一项研究。我们验证了两种疾病特异性问卷的意大利语版本,以评估颅颈肌张力障碍患者的 QoL。这些量表在临床实践和临床试验中都可能有用。

相似文献

1
Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)".颅颈肌张力障碍患者的生活质量:“颈椎肌张力障碍影响量表(CDIP-58)”和“颅颈肌张力障碍问卷(CDQ-24)”的意大利验证。
Neurol Sci. 2014 Jul;35(7):1053-8. doi: 10.1007/s10072-014-1642-7. Epub 2014 Jan 30.
2
Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.颅颈肌张力障碍问卷(CDQ - 24):一种疾病特异性生活质量工具的开发与验证
J Neurol Neurosurg Psychiatry. 2004 May;75(5):749-53. doi: 10.1136/jnnp.2003.013441.
3
Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.评价肉毒毒素治疗颈肌张力障碍患者及其家属的焦虑和抑郁量表以及生活质量。
Neurol Sci. 2019 Apr;40(4):725-731. doi: 10.1007/s10072-019-3719-9. Epub 2019 Jan 18.
4
Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study.A型肉毒毒素治疗后颈部肌张力障碍患者的生活质量:一项为期24周的前瞻性研究。
Neuropsychiatr Dis Treat. 2017 Jan 10;13:127-132. doi: 10.2147/NDT.S116325. eCollection 2017.
5
Content overlap of 91 dystonia symptoms among the seven most commonly used cervical dystonia scales.七种最常用的颈肌张力障碍量表中 91 个肌张力障碍症状的内容重叠。
Neurol Sci. 2024 Apr;45(4):1507-1514. doi: 10.1007/s10072-023-07157-1. Epub 2023 Nov 1.
6
Craniocervical Dystonia Questionnaire (CDQ-24): validation and cross-cultural adaptation in Serbian patients.颅颈肌张力障碍问卷(CDQ - 24):塞尔维亚患者中的效度验证与跨文化调适
Coll Antropol. 2009 Dec;33(4):1185-9.
7
Impact of Neu-botulinumtoxinA on the Severity and Quality of Life of Cervical Dystonia Patients.新型A型肉毒杆菌毒素对颈部肌张力障碍患者严重程度及生活质量的影响
Tremor Other Hyperkinet Mov (N Y). 2016 Aug 4;6:407. doi: 10.7916/D8736R2H. eCollection 2016.
8
Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.长期肉毒毒素治疗痉挛性斜颈患者的生活质量:一项横断面研究的结果。
Parkinsonism Relat Disord. 2018 Dec;57:63-67. doi: 10.1016/j.parkreldis.2018.07.019. Epub 2018 Jul 31.
9
Validation of the Turkish version of the Celiac Disease Questionnaire (CDQ).乳糜泻问卷(CDQ)土耳其语版本的验证
Health Qual Life Outcomes. 2015 Jun 19;13:82. doi: 10.1186/s12955-015-0272-y.
10
The physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystonia.在颈部肌张力障碍患者的生活质量中,身体、社会和情感方面受到的影响最大。
Arq Neuropsiquiatr. 2014 Jun;72(6):405-10. doi: 10.1590/0004-282x20140044.

引用本文的文献

1
Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.评价肉毒毒素治疗颈肌张力障碍患者及其家属的焦虑和抑郁量表以及生活质量。
Neurol Sci. 2019 Apr;40(4):725-731. doi: 10.1007/s10072-019-3719-9. Epub 2019 Jan 18.
2
SF-36 total score as a single measure of health-related quality of life: Scoping review.作为健康相关生活质量单一衡量指标的SF-36总分:范围综述
SAGE Open Med. 2016 Oct 4;4:2050312116671725. doi: 10.1177/2050312116671725. eCollection 2016.
3
Development and validation of a clinical scale for rating the severity of blepharospasm.

本文引用的文献

1
Dystonia rating scales: critique and recommendations.肌张力障碍评定量表:评价与建议。
Mov Disord. 2013 Jun 15;28(7):874-83. doi: 10.1002/mds.25579.
2
Nonmotor manifestations of dystonia: a systematic review.肌张力障碍的非运动症状:系统评价。
Mov Disord. 2011 Jun;26(7):1206-17. doi: 10.1002/mds.23709. Epub 2011 Apr 11.
3
The epidemiology of primary dystonia: current evidence and perspectives.原发性肌张力障碍的流行病学:当前证据与展望。
眼睑痉挛严重程度评定临床量表的编制与验证
Mov Disord. 2015 Apr;30(4):525-30. doi: 10.1002/mds.26156.
Eur J Neurol. 2010 Jul;17 Suppl 1:9-14. doi: 10.1111/j.1468-1331.2010.03053.x.
4
Depression in focal, segmental and generalized dystonia.局灶性、节段性和全身性肌张力障碍中的抑郁。
J Neurol. 2008 Nov;255(11):1750-5. doi: 10.1007/s00415-008-0020-x. Epub 2008 Nov 13.
5
Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.影响痉挛性斜颈患者健康相关生活质量的因素及A型肉毒毒素注射的影响
Funct Neurol. 2007 Apr-Jun;22(2):95-100.
6
Quality of life in focal, segmental, and generalized dystonia.局灶性、节段性和全身性肌张力障碍的生活质量
Mov Disord. 2007 Feb 15;22(3):341-7. doi: 10.1002/mds.21234.
7
CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.CDIP - 58可衡量肉毒杆菌毒素治疗颈部肌张力障碍的效果。
Neurology. 2006 Dec 26;67(12):2230-2. doi: 10.1212/01.wnl.0000249310.25427.f2.
8
Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58).了解肌张力障碍给患者带来的真实负担:颈部肌张力障碍影响量表(CDIP - 58)。
Neurology. 2004 Nov 9;63(9):1629-33. doi: 10.1212/01.wnl.0000142962.11881.26.
9
Epidemiology of primary dystonia.原发性肌张力障碍的流行病学
Lancet Neurol. 2004 Nov;3(11):673-8. doi: 10.1016/S1474-4422(04)00907-X.
10
Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.颅颈肌张力障碍问卷(CDQ - 24):一种疾病特异性生活质量工具的开发与验证
J Neurol Neurosurg Psychiatry. 2004 May;75(5):749-53. doi: 10.1136/jnnp.2003.013441.